SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admitted affair with a woman reported to be a suspected Chinese spy, and Nvidias board investigation into whether he was targeted by foreign intelligence, are driving concern about governance, leadership, and possible security or export-control fallout. Traders are split between expecting further pressure if the investigation threatens Huangs role or Nvidias business and treating the selloff as an overreaction and buying opportunity.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Nvidia CEO Jensen Huangs reported relationship with a suspected Chinese intelligence asset and the resulting scrutiny have traders speculating that customers or investors could rotate toward AMD. Others caution that broader AI-chip volatility, data-center regulation concerns, and doubts about whether AMDs rebound can hold may weigh on the sector.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The upcoming Q3 results are driving attention, with traders focused on Briumvi sales momentum and any update on the subcutaneous formulations Phase 3 timeline. The run-up has fueled bullish short-squeeze and buyout speculation, while some investors caution that earnings may not justify the move.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp slide amid a broader crypto-market selloff has traders focused on whether it can hold near the $1 area, with some warning of further losses and others buying or averaging down. The decline is also fueling criticism that Ripples partnerships and positive headlines have not translated into XRP price gains, while some traders speculate that political uncertainty is weighing on crypto.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Attention is centered on Legend Biotechs upcoming Q3 call, with CARVYKTI sales already reported and traders looking for detail on margins and the outlook; many are also anticipating more LB2501 in-vivo CAR-T data. Speculation that strong data could prompt a Novartis or J&J deal is unconfirmed, and some traders remain focused on execution and the stocks volatile price action.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Anticipation around Senseonics scheduled Q3 results and conference call is driving attention, with traders focused on whether Eversense CGM sales and adoption can sustain recent growth. Optimism about a strong report is tempered by concerns over cash burn, execution and the risk of a sell-the-news reaction.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Discussion centers on the FDAs November 22 decision on deramiocel for Duchenne muscular dystrophy, particularly whether HOPE-3 upper-limb data support approval; 28 trial investigators have urged the agency to approve the treatment. Many traders are optimistic and point to short interest and call-option activity, while others stress the binary risk of a rejection or narrower-than-hoped label.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus BOT+BAL update reporting long-term survival in heavily pretreated MSS metastatic colorectal cancer is driving attention, alongside discussion of the planned Phase 3 ROBBIN trial. Bullish traders see the results as evidence of promise in difficult-to-treat tumors, while skeptics question the small, nonrandomized data and continue to flag execution and dilution risks.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

COIN is drawing attention after a steep post-earnings selloff, with traders focused on weaker crypto trading activity, a Morgan Stanley downgrade, and broader crypto-market weakness amplified by concerns over the Binance hack. Bears point to fresh lows and pressure on Coinbases revenue outlook, while some investors argue the drop is overdone and are buying for a rebound or potential customer shifts to Coinbase.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPaths order for more than 50,000 optical assemblies for defense drone cameras is driving attention, with traders viewing it as evidence of rising defense demand and potential production growth. The community is also watching upcoming quarterly results for confirmation, while some remain cautious about the stocks sharp prior decline and whether the order will translate into sustained revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
